-+ 0.00%
-+ 0.00%
-+ 0.00%

Nexgel appoints Sequence LifeScience CEO Kieser, COO Harris to board

PUBT·05/12/2026 20:32:30
Listen to the news
Nexgel appoints Sequence LifeScience CEO Kieser, COO Harris to board
  • Nexgel appointed Brian J. Kieser and Kevin Harris to board of directors on May 6, 2026.
  • Kieser is chief executive officer of Sequence LifeScience; Harris is chief operating officer of Sequence LifeScience.
  • Sequence LifeScience led financing tied to acquisition of Celularity degenerative disease segment, including a $5.5 million strategic investment.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nexgel Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-022503), on May 12, 2026, and is solely responsible for the information contained therein.